Research and Markets (http://www.researchandmarkets.com/research/63gztd/global) has announced the addition of the "Global Non-Hodgkin's Lymphoma Epidemiology and Patient Flow Analysis - 2015" report to their offering.
The report provides insights into Non-Hodgkin's Lymphoma epidemiology, Non-Hodgkin's Lymphoma diagnosed patients, and Non-Hodgkin's Lymphoma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Non-Hodgkin's Lymphoma derived from epidemiological analysis, percentage of patients diagnosed with Non-Hodgkin's Lymphoma, and percentage of patients treated with Non-Hodgkin's Lymphoma therapy.
The study helps executives estimate Non-Hodgkin's Lymphoma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Non-Hodgkin's Lymphoma prevalence, Non-Hodgkin's Lymphoma diagnosis rate, and Non-Hodgkin's Lymphoma treatment rate for the period 2014 - 2020.
Key Features of the Report:
- Non-Hodgkin's Lymphoma: Disease Definition
- Non-Hodgkin's Lymphoma Patient Flow
- Non-Hodgkin's Lymphoma Prevalence
- Non-Hodgkin's Lymphoma Diagnosed Patients
- Non-Hodgkin's Lymphoma Treated Patients
Key Topics Covered:
1. Non-Hodgkin's Lymphoma: Disease Definition
2. Global Non-Hodgkin's Lymphoma Patient Flow
3. Non-Hodgkin's Lymphoma Patient Flow in the US
4. Non-Hodgkin's Lymphoma Patient Flow in Europe
5. Non-Hodgkin's Lymphoma Patient Flow in Germany
6. Non-Hodgkin's Lymphoma Patient Flow in France
7. Non-Hodgkin's Lymphoma Patient Flow in Spain
8. Non-Hodgkin's Lymphoma Patient Flow in Italy
9. Non-Hodgkin's Lymphoma Patient Flow in UK
10. Non-Hodgkin's Lymphoma Patient Flow in Japan
11. Appendix
For more information visit http://www.researchandmarkets.com/research/63gztd/global
